Medtronic PLC (MDT) Insider Sells 46,016 Shares
Insider Smith Gregory L sold 46,016 shares of Medtronic PLC (MDT) on November 18, 2025.
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
Latest news, analyst ratings, earnings reports, dividends, insider trades, and market analysis for Medtronic PLC.
Last Updated: Dec 11, 2025, 11:03 PM · Source: Finnhub.io
Insider Smith Gregory L sold 46,016 shares of Medtronic PLC (MDT) on November 18, 2025.
Goldman Sachs has upgraded Medtronic PLC (MDT) to Neutral from Sell.
Medtronic PLC (MDT) exceeds Q2 2026 earnings expectations.